Kurin Commends the CDC for Their Recent Publication on Blood Culture Contamination

SAN DIEGO–(BUSINESS WIRE)–Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets, commends the Centers for Disease Control and Prevention (CDC) for their just-released publication on blood culture contamination. The paper stresses the importance of reducing these preventable contaminations and highlights how devices, like Kurin, have been shown to be effective in … [Read more…]

Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

PIOMBINO DESE, Italy–(BUSINESS WIRE)–Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in the Virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum taking place on March 21 and March 22, 2023. … [Read more…]

Global Medical Device Contract Research Organization Market Report 2023 to 2030: Increasing Complexity in Product Design and Engineering Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Medical Device Contract Research Organization Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Service (Regulatory/Medical Affairs, Clinical Monitoring), By Type, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering. The global medical device contract research organization market size is expected to reach USD … [Read more…]

Global Psychiatry Partnering Deal Trends, Players and Financials Directory/Report 2016-2023 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Psychiatry Partnering 2016-2023: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. The report provides the full collection of psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2016. Most of the deals included within the report occur when a licensee obtains a right or an … [Read more…]

PMC Group and The Chakrabarti Foundation Make Donation to Ramakrishna Mission Saradapitha Belur Math of West Bengal

MOUNT LAUREL, N.J.–(BUSINESS WIRE)–Paritosh M. Chakrabarti, business owner, author and philanthropist, today announced PMC Group and The Chakrabarti Foundation have made a sizeable donation of land and property to the Ramakrishna Mission Saradapitha Belur Math of West Bengal. “Contributing to the Ramakrishna Mission Saradapitha is an honor. The Mission enshrines the teachings of India’s greatest … [Read more…]

Ellipses Pharma: EP0042 Receives Orphan Drug Designation from the US Food and Drug Administration

EP0042 is currently being investigated as a potential treatment option for patients with acute myeloid leukaemia LONDON–(BUSINESS WIRE)–Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an innovative drug development model, today announces that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug … [Read more…]

Global Wellness Company Fine Hygienic Holding Launches eon Longevity, a Powdered Beverage Supplement

All-Natural, Herbal, Clinically-Tested Beverage Supplement Offers Proven Health Benefits AMMAN, Jordan & DUBAI, U.A.E.–(BUSINESS WIRE)–Fine Hygienic Holding (FHH), one of the world’s leading wellness groups, today announced the launch of eon™, a powdered, herbal beverage supplement that supports overall health and longevity. Comprised of an all-natural, proprietary herbal blend, eon Longevity +Plus (eon’s signature product) … [Read more…]

AlgoTx Raises €20M to Conduct ATX01’s Phase 2 Program in Peripheral Neuropathic Pain

SURESNES, France–(BUSINESS WIRE)–European biotech AlgoTx, the developer of first-in-class treatment ATX01 for chemotherapy-induced peripheral neuropathy (CIPN), announced today the success of a €20M Series B fundraising led by Relyens Innovation Santé / Turenne Capital , followed by UI Investissement, and historical investors Bpifrance through its Innobio 2 fund and Omnes Capital. Early and new business … [Read more…]

Sensorion Announces Agenda For R&D Day Showcasing Gene Therapy For Inner Ear Disease

Thursday April 6, 2023, at 8am EDT, 2pm CEST MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion, (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company, specialising in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, announces the agenda for its R&D Day on Thursday 6 April 2023, at 8am … [Read more…]

Innovation in Resistance Management: VECTRONTM T500, a New Vector Control Product, is Prequalified by the World Health Organization (WHO)

Mitsui Chemicals Agro, Inc. (Tokyo; President & CEO: OZAWA Satoshi) today announce that their Indoor Residual Spray (IRS) for malaria control, VECTRONTM T500, has been prequalified by the WHO*1). TOKYO–(BUSINESS WIRE)–VECTRONTM T500 is a new IRS product containing TENEBENALTM, the world’s first meta-diamide active ingredient (IRAC Group 30) developed by Mitsui Chemicals Agro which has … [Read more…]